Who
Sagar Lonial
Director
Company insider
Files Form 4 as: Director, TG Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $2.2M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 22 Jun 2020
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | TGTX TG Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,325 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | TGTX TG Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,325 at $0.00 | filing |
| 11 Sep 2025filed 12 Sep 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $672K20,852 at $32.24 | filing |
| 12 Jun 2025filed 16 Jun 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —14,718 at $0.00 | filing |
| 11 Nov 2024filed 12 Nov 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $152K5,000 at $30.44 | filing |
| 20 Jun 2024filed 20 Jun 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $276K16,348 at $16.87 | filing |
| 19 Jun 2024filed 20 Jun 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —22,250 at $0.00 | filing |
| 17 Jun 2024filed 20 Jun 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $157K9,585 at $16.39 | filing |
| 13 Mar 2024filed 15 Mar 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $80K5,000 at $15.94 | filing |
| 28 Sep 2023filed 29 Sep 2023 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 23 Jun 2023filed 26 Jun 2023 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $815K34,854 at $23.37 | filing |
| 20 Jul 2022filed 22 Jul 2022 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —43,732 at $0.00 | filing |
| 18 Jun 2021filed 22 Jun 2021 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 22 Jun 2020filed 2 Jul 2020 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
News
TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026TGTX · simcoereformer.ca · 8 Oct 2026
0 headlines in the last 90 days name Sagar Lonial; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.